Unique Metabolic Signature Predicts Transition to T2D After Gestational Diabetes
Amino acid dysmetabolism can be detected during the early postpartum period and is predictive of the transition from gestational diabetes to type 2 diabetes.
Amino acid dysmetabolism can be detected during the early postpartum period and is predictive of the transition from gestational diabetes to type 2 diabetes.
Medical societies from the United Kingdom, Canada, and Australia have released recommendations for modification of testing during the COVID-19 pandemic.
Early diagnosis and treatment of gestational diabetes mellitus in high-risk women improves gestational weight gain.
Increased risk for GDM seen across all levels of prepregnancy BMI and gestational weight gain.
Children of women with diabetes diagnosed before or during pregnancy are at increased risk for early-onset cardiovascular disease.
Venlafaxine, amitriptyline use during pregnancy associated with increased risk for gestational diabetes.
But no reduction seen in risk for adverse composite maternal, offspring complications with Med diet.
Using metformin as first-line therapy for gestational diabetes may improve patient satisfaction and has similar efficacy and pregnancy outcomes to insulin.
Association even stronger for women persistently deficient through the second trimester.
Women at risk for GDM who are screened, those diagnosed with GDM not at increased risk.